HRP20080129T3 - Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders - Google Patents

Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Info

Publication number
HRP20080129T3
HRP20080129T3 HR20080129T HRP20080129T HRP20080129T3 HR P20080129 T3 HRP20080129 T3 HR P20080129T3 HR 20080129 T HR20080129 T HR 20080129T HR P20080129 T HRP20080129 T HR P20080129T HR P20080129 T3 HRP20080129 T3 HR P20080129T3
Authority
HR
Croatia
Prior art keywords
disorders
carbon atoms
halogen
alkyl
derivatives
Prior art date
Application number
HR20080129T
Other languages
English (en)
Croatian (hr)
Inventor
Volk Bal�zs
Bark�czy J�zsef
Simig Gyula
Mezei Tibor
Kapillern� Dezsofi Rita
Gacs�lyi Istv�n
Pallagi Katalin
Gigler G�bor
L�vay Gy�rgy
M�ricz Krisztina
Leveleki Csilla
Sziray N�ra
Sz�n�si G�bor
Egyed Andr�s
G�bor H�rsing L�szl�
Original Assignee
EGIS Gy�gyszergy�r Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0400955A external-priority patent/HU0400955D0/hu
Priority claimed from HU0500463A external-priority patent/HUP0500463A3/hu
Application filed by EGIS Gy�gyszergy�r Nyrt filed Critical EGIS Gy�gyszergy�r Nyrt
Publication of HRP20080129T3 publication Critical patent/HRP20080129T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR20080129T 2004-05-11 2005-05-11 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders HRP20080129T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0400955A HU0400955D0 (en) 2004-05-11 2004-05-11 Pyridine derivatives of dialkyl oxindoles
HU0500463A HUP0500463A3 (en) 2005-05-05 2005-05-05 Pyridine derivatives of dialkyl-oxindoles
PCT/HU2005/000051 WO2005108390A1 (en) 2004-05-11 2005-05-11 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Publications (1)

Publication Number Publication Date
HRP20080129T3 true HRP20080129T3 (en) 2008-04-30

Family

ID=89985998

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20080129T HRP20080129T3 (en) 2004-05-11 2005-05-11 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
HR20060403A HRP20060403A2 (en) 2004-05-11 2005-05-11 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20060403A HRP20060403A2 (en) 2004-05-11 2005-05-11 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders

Country Status (21)

Country Link
US (2) US20070232662A1 (de)
EP (1) EP1751138B9 (de)
JP (1) JP2007537228A (de)
KR (1) KR20070014189A (de)
AT (1) ATE382045T1 (de)
AU (1) AU2005240844A1 (de)
BG (1) BG109770A (de)
CA (1) CA2566426A1 (de)
CZ (1) CZ2006772A3 (de)
DE (1) DE602005004024T2 (de)
EA (1) EA010865B1 (de)
ES (1) ES2299033T3 (de)
HR (2) HRP20080129T3 (de)
IL (1) IL179030A0 (de)
MX (1) MXPA06013065A (de)
NO (1) NO20065661L (de)
PL (2) PL1751138T3 (de)
PT (1) PT1751138E (de)
RS (1) RS20060622A (de)
SK (1) SK51062006A3 (de)
WO (1) WO2005108390A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751134A1 (de) * 2004-05-11 2007-02-14 EGIS Gyógyszergyár Nyrt Pyridinderivate von alkyloxindolen als auf den 5-ht7-rezeptor wirkende mittel
MXPA06013069A (es) 2004-05-11 2007-03-30 Egis Gyogyszergyar Nyrt Derivados de 3-(((4-fenil) -piperazin-1-il) -alquil)-3 -alquil-1, 3-dihidro-2h -indol-2 -ona y compuestos relacionados para el tratamiento de trastornos del sistema nervioso central.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
US6407112B1 (en) * 1998-04-22 2002-06-18 Meiji Seika Kaisha, Ltd. Optically active tetrahydrobenzindole derivative
FR2779429B1 (fr) * 1998-06-03 2000-07-13 Synthelabo Derives d'oxindole, leurs preparations et leurs applications en therapeutique
AR035521A1 (es) * 2000-12-22 2004-06-02 Lundbeck & Co As H Derivados de 3-indolina y composicion farmaceutica que los comprende

Also Published As

Publication number Publication date
EP1751138B9 (de) 2008-11-12
DE602005004024D1 (de) 2008-02-07
WO2005108390A1 (en) 2005-11-17
US20090281137A1 (en) 2009-11-12
ATE382045T1 (de) 2008-01-15
EP1751138A1 (de) 2007-02-14
PL381614A1 (pl) 2007-06-11
MXPA06013065A (es) 2007-05-04
SK51062006A3 (sk) 2007-04-05
IL179030A0 (en) 2007-03-08
HRP20060403A2 (en) 2007-04-30
RS20060622A (sr) 2008-06-05
KR20070014189A (ko) 2007-01-31
PT1751138E (pt) 2008-02-25
DE602005004024T2 (de) 2008-12-24
EA010865B1 (ru) 2008-12-30
PL1751138T3 (pl) 2008-05-30
EA200602082A1 (ru) 2007-04-27
CA2566426A1 (en) 2005-11-17
JP2007537228A (ja) 2007-12-20
EP1751138B1 (de) 2007-12-26
NO20065661L (no) 2007-02-08
CZ2006772A3 (cs) 2007-03-14
US20070232662A1 (en) 2007-10-04
BG109770A (bg) 2008-05-30
AU2005240844A1 (en) 2005-11-17
ES2299033T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
HRP20040429B1 (hr) Derivati sulfonamida, njihova priprema i upotrebakao lijekova
HRP20080477T3 (en) Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
YU48714B (sh) Derivati benzofurana, benzotiofena, indola i indolizina i postupak za njihovo dobijanje
HRP20171740T1 (hr) Derivati 5-((halofenil)-3-hidroksi-piridin-2-yl-karboksilne kiseline kao posrednici za pripravu karbonilamino alkanoinskih kiselina, njihovih estera i amida
HRP20080022T3 (en) Pyrrolopyridine derivatives and their use as crth2 antagonists
PE20040512A1 (es) Compuesto de pirazol-pirimidina anilina
HRP20080186T3 (en) Use of tricyclic compounds as glycine transport inhibitors
ATE556058T1 (de) 1-(2h)-isochinolonderivat
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
NO20005357L (no) Sulfonamidholdige indolforbindelser
DK419086A (da) Heterocykliske substituerede indoler, mellemprodukter, fremgangsmaader til fremstilling heraf og laegemidler
EA200100428A1 (ru) Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
BRPI0506817A (pt) inibidores seletivos de quinase
HRP20020109B1 (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
KR910004760A (ko) 부식 억제제로서 케토산의 특정 아민 염을 함유하는 도료 조성물
EA201391537A1 (ru) ЭТИНИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ mGluR5
HRP20070498T3 (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
HRP20080119T3 (en) Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
AR072103A1 (es) Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen
AR023111A1 (es) Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden
HRP20080129T3 (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
HRP20080097T5 (en) Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
EA200900921A1 (ru) НОВЫЕ СОЕДИНЕНИЯ АМИНОПИРРОЛО[1,2-a]ИНДОЛА И АМИНОПИРИДАЗИНО[1,6-a]ИНДОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
AR002259A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados.